Results 51 to 60 of about 274 (96)
Some of the next articles are maybe not open access.

Abstracts of the 2022 SPP Spring Meeting

Pediatric and Developmental Pathology, 2022
Background: The implementation of next-generation sequencing in combination with sensitive software tools for cancer diagnosis has markedly increased the ability to detect genetic abnormalities. Such assays have resulted in accurate diagnoses and allowed
Nos   +10 more
semanticscholar   +1 more source

2022 Annual Meeting of The North American Menopause Society October 12 - 15, 2022, Atlanta, GA.

Menopause, 2022
Objective: Hot flashes are a common side effect of endocrine therapy (ET) in breast cancer survivors. Hot flashes are associated with poor quality of life and treatment nonadherence. The Embr Wave is a noninvasive wearable device that applies cooling and
A. Vetter   +14 more
semanticscholar   +1 more source

2022 CCCC Chair’s Letter

College Composition & Communication, 2022
Hassel officially started his service as an elected CCCC officer on Dec 23, 2019, but for four years prior to that, he was an ex officio member of the CCCC Executive Committee (EC) by virtue of his role as editor of Teaching English in the Two-Year ...
H. Hassel
semanticscholar   +1 more source

Performance Analysis of 81.6 kWp Roof-top Solar PV Installed on Canopy Structure at WRLDC, Mumbai

National Power Systems Conference, 2022
Government of India has set the target of 175GW of Renewable Energy (RE) Capacity by Dec 2022 [1]. This will have impact on generation from fossil fuel in India and reduce the carbon footprint.
P. Prajapati   +6 more
semanticscholar   +1 more source

Abstract 5275: The short-term impact of COVID-19 on lung cancer screening participation and adherence

Cancer Research, 2022
Objective: Screening with low-dose CT (LDCT) effectively reduces mortality from lung cancer. Elective imaging procedures, including lung cancer screening (LCS) LDCT exams, were paused during the height of the COVID-19 pandemic at our institution to ...
Yannan Lin   +3 more
semanticscholar   +1 more source

Abstract CT187: Phase 1 Trial of RTX-240, allogeneic red blood cells engineered to express 4-1BBL and trans-presented IL-15, in patients (Pts) with advanced solid tumors

Cancer Research, 2022
Background: RTX-240 is an allogeneic cellular therapy genetically engineered to express high copy numbers of trimeric 4-1BBL and IL-15/IL-15Rα fusion proteins on the RBC surface membrane.
O. Hamid   +13 more
semanticscholar   +1 more source

Abstract CT505: Phase I study of D-1553 to assess safety and efficacy in patients with non-small cell lung cancer (NSCLC) harboring KRASG12C mutation

Cancer Research, 2022
Background: KRASG12C mutation acts as an oncogenic driver and occurs in ~15% of NSCLC. D-1553 is a novel and potent small molecule inhibitor of KRASG12C. Here we present the safety, tolerability, pharmacokinetics (PK) and preliminary efficacy of D-1553
H. Jian   +16 more
semanticscholar   +1 more source

Abstract LB139: The RNA signature of immune-related genes and distinct spatial distribution of immune cells are closely associated with the treatment outcomes in the malignant melanoma patients receiving immune checkpoint inhibitors

Cancer Research, 2022
Introduction: The immune checkpoint inhibitors (ICIs) against CTLA-4 and PD-1/PD-L1, have improved survival with long-term durable response for advanced malignant melanomas.
Seoree Kim   +10 more
semanticscholar   +1 more source

Abstract 5232: Next-generation sequencing revealed clonal architecture and faciliated diagnosis of patients with multiple lung tumors: An analysis of 12 cases

Cancer Research, 2022
Diagnosing multiple lung tumors as multiple primary lung cancer (MPLC) or intrapulmonary metastasis (IPM) has important therapeutic implications.
Wenyang Jiang   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy